Building Bridges from Research to Therapy.
Lonza's Pluripotent Stem Cell Innovation Center
Lonza Bioscience established a new strategic vision to become the leading supplier to the regenerative medicine industry. To realize this vision, Lonza created the Pluripotent Stem Cell Innovation Center. Pluripotent stem cells have the ability to generate any of the 220+ cell types in the human body. And because of this unique attribute, these cells have great potential in basic research, drug discovery and cell replacement therapies.